0001567619-21-004470.txt : 20210218 0001567619-21-004470.hdr.sgml : 20210218 20210218184308 ACCESSION NUMBER: 0001567619-21-004470 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210216 FILED AS OF DATE: 20210218 DATE AS OF CHANGE: 20210218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAWLIS V BRYAN CENTRAL INDEX KEY: 0001247681 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 21651193 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2021-02-16 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001247681 LAWLIS V BRYAN C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949 1 0 0 0 Common Stock 2021-02-16 4 M 0 7500 26.49 A 26350 D Common Stock 2021-02-16 4 S 0 7500 87.41 D 18850 D Stock Option (Right to buy Common Stock) 26.49 2021-02-16 4 M 0 7500 0 D 2011-11-12 2021-05-11 Common Stock 7500 7500 D Trade made pursuant to a 10b5-1 plan executed on January 16, 2020, as amended on August 21, 2020. Reflects the number of options outstanding after the transactions from this specific stock option grant. /s/ Eric Fleekop, Attorney-in-Fact 2021-02-18